XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical Data Pipeline for Data Review and Analyses.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

VirTrial

JANUARY 10, 2020

The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies. The company was selected for its industry leading Virtual Care Management (VCM) program. To learn more about VirTrial, visit [link].

Clinical Trials 97

Clinical Trials Clinical Trials Clinical Research Pharma Companies 97

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

Life Science 105

Life Science Clinical Trials Clinical Trials Trials 105

pharmaphorum

AUGUST 31, 2021

ECAs are being used to support the primary approval, label expansion of their assets and even go/no-go decisions for trials. For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. Myth 1: There are too many challenges with adopting an ECA.

Clinical Trials 89

Clinical Trials Clinical Trials Life Science Trials 89

Drug Discovery World

OCTOBER 16, 2023

Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. “The Saama Technologies, Inc. , Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

XTalks

JANUARY 15, 2024

The field of clinical research will witness significant advancements in 2024. Read on to learn about the top 10 clinical trial trends for 2024, and be sure to explore and join upcoming webinars about clinical trials at Xtalks. percent from 2023 to 2033.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

Drug Discovery World

JANUARY 24, 2023

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 However, it also made great strides in proving the success of these sorts of trials.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.

Life Science 97

Life Science Medicine Clinical Trials Clinical Trials 97

pharmaphorum

APRIL 7, 2021

With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharma companies and will aim to keep more product rights than it did in the past. Role models.

Antibody 91

Antibody Life Science Development Regulation 91

Cloudbyz

MAY 19, 2021

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. However, the major challenge is the newness and uncharted territory of the CGT field for service companies.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

XTalks

NOVEMBER 16, 2021

deVries co-founded Medidata in 1999 as a provider of technological software solutions to advance clinical research. Dassault Systèmes acquired the company in 2019 and de Vries was serving as the Life Sciences & Healthcare vice-chair for the new parent company.

Life Science 98

Life Science Clinical Research Pharma Companies Engineer 98

XTalks

SEPTEMBER 5, 2023

Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies. In the majority of cases, the risk of VAED is brought to light during preclinical stages or early clinical trial phases.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

Drug Discovery World

OCTOBER 7, 2022

It is about going faster in progressing our innovation to market, taking things further along the value chain as we de-risk the early science. It’s about working together with our partners in the life science sector to get world class innovations to patients. . Hamish Ryder. Tony Hickson.

HR 52

HR Research Drugs Development 52

XTalks

OCTOBER 1, 2020

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. The drug is currently in clinical trials for alcoholic hepatitis (AH), nonalcoholic steatohepatitis (NASH), as well as in COVID-19 patients with acute liver or kidney injury.

Scientist 52

Scientist In-Vitro Research Life Science 52